Advances in cell therapy: progress and challenges in hematological and solid tumors

Cell-based therapies harness the endogenous ability of the immune system to fight cancer and have shown promising results in the treatment of hematological malignancies. However, their clinical application beyond B cell malignancies is hampered by numerous hurdles, ranging from relapsed disease to a...

Full description

Saved in:
Bibliographic Details
Main Authors: D'Avanzo, Claudia (Author) , Blaeschke, Franziska (Author) , Lysandrou, Memnon (Author) , Ingelfinger, Florian (Author) , Zeiser, Robert (Author)
Format: Article (Journal)
Language:English
Published: December 2024
In: Trends in pharmacological sciences
Year: 2024, Volume: 45, Issue: 12, Pages: 1119-1134
ISSN:1873-3735
DOI:10.1016/j.tips.2024.10.016
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.tips.2024.10.016
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0165614724002268
Get full text
Author Notes:Claudia D’Avanzo, Franziska Blaeschke, Memnon Lysandrou, Florian Ingelfinger, and Robert Zeiser

MARC

LEADER 00000caa a2200000 c 4500
001 1924651424
003 DE-627
005 20250717012658.0
007 cr uuu---uuuuu
008 250505s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.tips.2024.10.016  |2 doi 
035 |a (DE-627)1924651424 
035 |a (DE-599)KXP1924651424 
035 |a (OCoLC)1528045174 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a D'Avanzo, Claudia  |e VerfasserIn  |0 (DE-588)122815080X  |0 (DE-627)1749488655  |4 aut 
245 1 0 |a Advances in cell therapy  |b progress and challenges in hematological and solid tumors  |c Claudia D’Avanzo, Franziska Blaeschke, Memnon Lysandrou, Florian Ingelfinger, and Robert Zeiser 
264 1 |c December 2024 
300 |b Illustrationen 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 27. November 2024, Artikelversion: 5. Dezember 2024 
500 |a Gesehen am 05.05.2025 
520 |a Cell-based therapies harness the endogenous ability of the immune system to fight cancer and have shown promising results in the treatment of hematological malignancies. However, their clinical application beyond B cell malignancies is hampered by numerous hurdles, ranging from relapsed disease to a hostile tumor microenvironment (TME). Recent advances in cell engineering and TME modulation may expand the applicability of these therapies to a wider range of cancers, creating new treatment possibilities. Breakthroughs in advanced gene editing and sophisticated cell engineering, have also provided promising solutions to longstanding challenges. In this review, we examine the challenges and future directions of the most prominent cell-based therapies, including chimeric antigen receptor (CAR)-T cells, tumor-infiltrating lymphocytes (TILs), and natural killer (NK) cells, and emerging modalities. We provide a comprehensive analysis of emerging cell types and combination strategies translated into clinical trials, offering insights into the next generation of cell-based cancer treatments 
650 4 |a antitumor immune response 
650 4 |a CAR-T cells 
650 4 |a cell therapy 
650 4 |a tumor-infiltrating lymphocytes 
700 1 |a Blaeschke, Franziska  |d 1988-  |e VerfasserIn  |0 (DE-588)1223945812  |0 (DE-627)1743508867  |4 aut 
700 1 |a Lysandrou, Memnon  |e VerfasserIn  |4 aut 
700 1 |a Ingelfinger, Florian  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Zeiser, Robert  |d 1975-  |e VerfasserIn  |0 (DE-588)12346000X  |0 (DE-627)082568081  |0 (DE-576)293718016  |4 aut 
773 0 8 |i Enthalten in  |t Trends in pharmacological sciences  |d Amsterdam [u.a.] : Elsevier Science, 1979  |g 45(2024), 12, Seite 1119-1134  |h Online-Ressource  |w (DE-627)320490912  |w (DE-600)2011007-8  |w (DE-576)116726067  |x 1873-3735  |7 nnas  |a Advances in cell therapy progress and challenges in hematological and solid tumors 
773 1 8 |g volume:45  |g year:2024  |g number:12  |g pages:1119-1134  |g extent:16  |a Advances in cell therapy progress and challenges in hematological and solid tumors 
856 4 0 |u https://doi.org/10.1016/j.tips.2024.10.016  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0165614724002268  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250701  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20250505 
993 |a Article 
994 |a 2024 
998 |g 1223945812  |a Blaeschke, Franziska  |m 1223945812:Blaeschke, Franziska  |d 910000  |d 910500  |e 910000PB1223945812  |e 910500PB1223945812  |k 0/910000/  |k 1/910000/910500/  |p 2 
999 |a KXP-PPN1924651424  |e 4720034071 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1924651424","note":["Online verfügbar: 27. November 2024, Artikelversion: 5. Dezember 2024","Gesehen am 05.05.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Advances in cell therapy","title":"Advances in cell therapy","subtitle":"progress and challenges in hematological and solid tumors"}],"person":[{"roleDisplay":"VerfasserIn","display":"D'Avanzo, Claudia","role":"aut","family":"D'Avanzo","given":"Claudia"},{"role":"aut","display":"Blaeschke, Franziska","roleDisplay":"VerfasserIn","given":"Franziska","family":"Blaeschke"},{"family":"Lysandrou","given":"Memnon","display":"Lysandrou, Memnon","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Ingelfinger","given":"Florian","roleDisplay":"VerfasserIn","display":"Ingelfinger, Florian","role":"aut"},{"given":"Robert","family":"Zeiser","role":"aut","roleDisplay":"VerfasserIn","display":"Zeiser, Robert"}],"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1979-","publisher":"Elsevier Science","dateIssuedKey":"1979"}],"id":{"issn":["1873-3735"],"zdb":["2011007-8"],"eki":["320490912"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Trends in pharmacological sciences","title_sort":"Trends in pharmacological sciences"}],"disp":"Advances in cell therapy progress and challenges in hematological and solid tumorsTrends in pharmacological sciences","note":["Gesehen am 28.05.20","Ungezählte Beil.: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320490912","language":["eng"],"pubHistory":["1.1979/80 -"],"part":{"issue":"12","pages":"1119-1134","year":"2024","extent":"16","text":"45(2024), 12, Seite 1119-1134","volume":"45"}}],"physDesc":[{"extent":"16 S.","noteIll":"Illustrationen"}],"id":{"eki":["1924651424"],"doi":["10.1016/j.tips.2024.10.016"]},"origin":[{"dateIssuedDisp":"December 2024","dateIssuedKey":"2024"}],"name":{"displayForm":["Claudia D’Avanzo, Franziska Blaeschke, Memnon Lysandrou, Florian Ingelfinger, and Robert Zeiser"]}} 
SRT |a DAVANZOCLAADVANCESIN2024